QIAGEN N.V. (QGEN) stock
QGENNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$49.75−0.06 (-0.12%)
Close on Nov 17, 2026Market cap $10.79BP/E 25.6Yield 0.50%
Qiagen enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Qiagen's enterprise value was $11.57B on Nov 11, 2026, against $11.53B a year earlier. Over the last 5 years it ranged from $8.12B to $14.91B, with a median of $11.29B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $11.57B | +6.3% |
| 2025 | Dec 31, 2025 | $10.88B | +1.4% |
| 2024 | Dec 31, 2024 | $10.72B | -2.2% |
| 2023 | Dec 29, 2023 | $10.97B | -16.0% |
| 2022 | Dec 30, 2022 | $13.06B | -12.4% |
| 2021 | Dec 31, 2021 | $14.91B | +9.9% |
| 2020 | Dec 31, 2020 | $13.56B | +49.3% |
| 2019 | Dec 31, 2019 | $9.09B | -1.1% |
| 2018 | Dec 31, 2018 | $9.19B | +10.5% |
| 2017 | Dec 29, 2017 | $8.32B | +8.5% |
| 2016 | Dec 30, 2016 | $7.67B | -0.0% |
| 2015 | Dec 31, 2015 | $7.67B | +18.9% |
| 2014 | Dec 31, 2014 | $6.45B | +2.5% |
| 2013 | Dec 31, 2013 | $6.30B | +31.2% |
| 2012 | Dec 31, 2012 | $4.80B | – |
| 2011 | Dec 30, 2011 | -$58.09M | -101.2% |
| 2010 | Dec 31, 2010 | $4.83B | +8.1% |
| 2009 | Dec 31, 2009 | $4.47B | – |
See a number that looks wrong?